SurgePays, Inc. — Form 8-K Summary
Reporting date: September 28, 2026. The filing reports Nasdaq listing-status developments; it does not provide quarterly or annual financial results.
Nasdaq listing status
- Nasdaq granted SurgePays an additional 180 calendar days, through March 22, 2027, to regain compliance with the $1.00 minimum bid-price requirement. The initial compliance period expired September 21, 2026.
- The extension was based on the company meeting the market-value-of-publicly-held-shares requirement and other applicable initial-listing requirements for the Nasdaq Capital Market, except the bid-price rule. The company stated it intends to cure the deficiency during the extension, potentially through a reverse stock split.
- Nasdaq separately determined that the company complies with the minimum stockholders’ equity requirement under Listing Rule 5550(b)(1), addressing a deficiency identified in Nasdaq’s March 18, 2026 letter. Nasdaq said compliance with continued-listing criteria will be assessed upon the next periodic report.
Financial metrics and changes
The filing provides no revenue, profit, cash flow, margin, debt, or liquidity figures and gives no financial guidance. It reports that the stockholders’ equity listing deficiency was resolved, while the bid-price deficiency remains subject to the extended compliance period.
Risks and contingencies
- If SurgePays fails to regain bid-price compliance by March 22, 2027, Nasdaq may notify the company that its securities will be delisted. The company may appeal, but a timely hearing request after the second compliance period would not stay a trading suspension.
- The extension applies only to the bid-price deficiency. The company remains subject to other Nasdaq listing requirements, and the filing gives no assurance that it will satisfy them or regain bid-price compliance.
- Delisting could reduce the stock’s liquidity and market price, limit investor interest and access to equity financing and public capital markets, and impair the company’s ability to provide equity incentives.
Important facts to verify
- Whether the stock meets Nasdaq’s $1.00 minimum bid-price requirement by March 22, 2027, and whether a reverse stock split is pursued.
- Whether the company demonstrates compliance with all continued-listing criteria in its next periodic report.
- Any subsequent Nasdaq notices, delisting action, or appeal proceedings.